aceRNA Technologies Co., Ltd.
PrivateLast Round
Series B
May 7, 2024
Est. Valuation
$11.3M
Total Funding Raised
$7.95M
Company Overview
aceRNA Technologies Co., Ltd. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series B round in May 2024.
aceRNA Technologies Co., Ltd. is a biotechnology company that develops mRNA-based and gene therapies using proprietary RNA Switch technology for cell-specific therapeutic expression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
aceRNA Technologies Co., Ltd. Comparables
Compare aceRNA Technologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Radar Therapeutics | 84% | |
| Combined Therapeutics | 83% | |
| Rgenta Therapeutics | 80% |
For institutional investors. Book with your work email.
aceRNA Technologies Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 7, 2024 | ||||
| Series B | Dec 20, 2021 | ||||
| Series A | Oct 31, 2019 | ||||
| Seed | Nov 8, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
aceRNA Technologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCI Partners Co., Ltd. | Series B |
| DCI Partners | Series B |
| Mitsubishi UFJ Capital | Series B |
| Kyoto University Innovation Capital | Seed, Series A |
| SMBC Venture Capital | Series A |
| UTokyo Innovation Platform Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 114% MoM.
- Mar 2, 2026
Monthly visitors grew 100% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
aceRNA Technologies Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about aceRNA Technologies Co., Ltd.'s valuation, stock price, and market status.
Is aceRNA Technologies Co., Ltd. a public or private company?
aceRNA Technologies Co., Ltd. is a private company.
What is the current stock price of aceRNA Technologies Co., Ltd.?
aceRNA Technologies Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks aceRNA Technologies Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is aceRNA Technologies Co., Ltd. worth (valuation)?
aceRNA Technologies Co., Ltd.'s valuation is estimated at $11.3M based on funding round data.
Can I buy aceRNA Technologies Co., Ltd. stock?
aceRNA Technologies Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was aceRNA Technologies Co., Ltd.'s last funding round?
aceRNA Technologies Co., Ltd.'s most recent funding round was Series B on May 7, 2024.
Who are the main investors in aceRNA Technologies Co., Ltd.?
Key investors in aceRNA Technologies Co., Ltd. include DCI Partners Co., Ltd., DCI Partners, Kyoto University Innovation Capital.
Will aceRNA Technologies Co., Ltd. IPO soon?
No public IPO plans have been announced for aceRNA Technologies Co., Ltd..
How can I track aceRNA Technologies Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in aceRNA Technologies Co., Ltd.'s shares on secondary markets.